{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T14:46:45Z","timestamp":1785336405008,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,1,16]],"date-time":"2016-01-16T00:00:00Z","timestamp":1452902400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Internal Research Grants of the University of Medicine and Pharmacy T\u00eergu Mure\u015f, Rom\u00e2nia","award":["19\/11.12.2013"],"award-info":[{"award-number":["19\/11.12.2013"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1007\/s13277-016-4815-6","type":"journal-article","created":{"date-parts":[[2016,1,16]],"date-time":"2016-01-16T06:10:27Z","timestamp":1452924627000},"page":"9357-9366","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Influence of XPC, XPD, XPF, and XPG gene polymorphisms on the risk and the outcome of acute myeloid leukemia in a Romanian population"],"prefix":"10.1007","volume":"37","author":[{"given":"Claudia","family":"B\u0103nescu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihaela","family":"Iancu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian P.","family":"Trifa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minodora","family":"Dobreanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeriu G.","family":"Moldovan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Duicu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florin","family":"Tripon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei","family":"Crauciuc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Skypnyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Bogli\u0219","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erzsebeth","family":"Lazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,16]]},"reference":[{"issue":"9","key":"4815_CR1","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.1182\/blood-2006-05-022111","volume":"109","author":"N Kuptsova","year":"2007","unstructured":"Kuptsova N, Kopecky KJ, Godwin J, Anderson J, Hoque A, Willman CL, et al. Polymorphisms in DNA repair genes and therapeutic outcomes of AML patients from SWOG clinical trials. Blood. 2007;109(9):3936\u201344.","journal-title":"Blood"},{"issue":"5","key":"4815_CR2","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s11912-002-0032-0","volume":"4","author":"C Schoch","year":"2002","unstructured":"Schoch C, Haferlach T. Cytogenetics in acute myeloid leukemia. Curr Oncol Rep. 2002;4(5):390\u20137.","journal-title":"Curr Oncol Rep"},{"key":"4815_CR3","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3324\/haematol.13345","volume":"93","author":"K D\u00f6hner","year":"2008","unstructured":"D\u00f6hner K, D\u00f6hner H. Molecular characterization of acute myeloid leukemia. Haematologica. 2008;93:976\u201382.","journal-title":"Haematologica"},{"issue":"22","key":"4815_CR4","doi-asserted-by":"crossref","first-page":"5221","DOI":"10.1182\/blood-2012-02-411215","volume":"119","author":"JC Hern\u00e1ndez-Boluda","year":"2012","unstructured":"Hern\u00e1ndez-Boluda JC, Pereira A, Cervantes F, Alvarez-Larr\u00e1n A, Collado M, Such E, et al. A polymorphism in the XPD gene predisposes to leukemic transformation and new nonmyeloid malignancies in essential thrombocythemia and polycythemia vera. Blood. 2012;119(22):5221\u20138.","journal-title":"Blood"},{"issue":"8","key":"4815_CR5","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/cncr.24205","volume":"115","author":"R El-Zein","year":"2009","unstructured":"El-Zein R, Monroy CM, Etzel CJ, Cortes AC, Xing Y, Collier AL, et al. Genetic polymorphisms in DNA repair genes as modulators of Hodgkin disease risk. Cancer. 2009;115(8):1651\u20139.","journal-title":"Cancer"},{"issue":"1","key":"4815_CR6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1182\/blood-2005-06-2305","volume":"107","author":"PA Mehta","year":"2006","unstructured":"Mehta PA, Alonzo TA, Gerbing RB, Elliott JS, Wilke TA, Kennedy RJ, et al. XPD Lys751Gln polymorphism in the etiology and outcome of childhood acute myeloid leukemia: a Children\u2019s Oncology Group report. Blood. 2006;107(1):39\u201345.","journal-title":"Blood"},{"issue":"4","key":"4815_CR7","first-page":"278","volume":"1","author":"N Kuptsova-Clarkson","year":"2010","unstructured":"Kuptsova-Clarkson N, Ambrosone CB, Weiss J, Baer MR, Sucheston LE, Zirpoli G, et al. XPD DNA nucleotide excision repair gene polymorphisms associated with DNA repair deficiency predict better treatment outcomes in secondary acute myeloid leukemia. Int J Mol Epidemiol Genet. 2010;1(4):278\u201394.","journal-title":"Int J Mol Epidemiol Genet"},{"issue":"4","key":"4815_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0094136","volume":"9","author":"Y Liu","year":"2014","unstructured":"Liu Y, Cao L, Chang J, Lin J, He B, Rao J, et al. XPF-673C\u2009>\u2009T polymorphism effect on the susceptibility to esophageal cancer in Chinese population. PLoS One. 2014;9(4), e94136. doi: 10.1371\/journal.pone.0094136 .","journal-title":"PLoS One"},{"issue":"6","key":"4815_CR9","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.3109\/10428194.2014.974045","volume":"56","author":"K Douzi","year":"2015","unstructured":"Douzi K, Ouerhani S, Menif S, Safra I, Abbes S. Polymorphisms in XPC, XPD and XPG DNA repair genes and leukemia risk in a Tunisian population. Leuk Lymphoma. 2015;56(6):1856\u201362.","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"4815_CR10","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3109\/10428190903582804","volume":"51","author":"SS Strom","year":"2010","unstructured":"Strom SS, Estey E, Outschoorn UM, Garcia-Manero G. Acute myeloid leukemia outcome: role of nucleotide excision repair polymorphisms in intermediate risk patients. Leuk Lymphoma. 2010;51(4):598\u2013605.","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"4815_CR11","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s12185-012-1145-3","volume":"96","author":"P Xu","year":"2012","unstructured":"Xu P, Chen B, Feng J, Cheng L, Xia G, Li Y, et al. Polymorphisms in XPC provide prognostic information in acute myeloid leukemia. Int J Hematol. 2012;96(4):450\u201360.","journal-title":"Int J Hematol"},{"issue":"6","key":"4815_CR12","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/mutage\/17.6.463","volume":"17","author":"S Benhamou","year":"2002","unstructured":"Benhamou S, Sarasin A. ERCC2\/XPD gene polymorphisms and cancer risk. Mutagenesis. 2002;17(6):463\u20139.","journal-title":"Mutagenesis"},{"issue":"1","key":"4815_CR13","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/ijc.25318","volume":"128","author":"JY Shi","year":"2011","unstructured":"Shi JY, Ren ZH, Jiao B, Xiao R, Yun HY, Chen B, et al. Genetic variations of DNA repair genes and their prognostic significance in patients with acute myeloid leukemia. Int J Cancer. 2011;128(1):233\u20138.","journal-title":"Int J Cancer"},{"issue":"12","key":"4815_CR14","doi-asserted-by":"crossref","first-page":"4871","DOI":"10.1182\/blood-2005-08-3272","volume":"107","author":"M Monzo","year":"2006","unstructured":"Monzo M, Brunet S, Urbano-Ispizua A, Navarro A, Perea G, Esteve J, et al. Genomic polymorphisms provide prognostic information in intermediate-risk acute myeloblastic leukemia. Blood. 2006;107(12):4871\u20139.","journal-title":"Blood"},{"key":"4815_CR15","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1182\/blood-2002-04-1152","volume":"10","author":"C Seedhouse","year":"2002","unstructured":"Seedhouse C, Bainton R, Lewis M, Harding A, Russell N, Das-Gupta E. The genotype distribution of the XRCC1 gene indicates a role for base excision repair in the development of therapy-related acute myeloblastic leukemia. Blood. 2002;10:3761\u20136.","journal-title":"Blood"},{"issue":"3","key":"4815_CR16","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1089\/gtmb.2012.0278","volume":"17","author":"A Sorour","year":"2013","unstructured":"Sorour A, Ayad MW, Kassem H. The genotype distribution of the XRCC1, XRCC3, and XPD DNA repair genes and their role for the development of acute myeloblastic leukemia. Genet Test Mol Biomarkers. 2013;17(3):195\u2013201.","journal-title":"Genet Test Mol Biomarkers"},{"issue":"5","key":"4815_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0088490","volume":"9","author":"X-F He","year":"2014","unstructured":"He X-F, Liu L-R, Wei W, Liu Y, Su J, Wang S-L, et al. Association between the XPG Asp1104His and XPF Arg415Gln polymorphisms and risk of cancer: a meta-analysis. PLoS One. 2014;9(5), e88490. doi: 10.1371\/journal.pone.0088490 .","journal-title":"PLoS One"},{"issue":"6","key":"4815_CR18","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.3892\/mco.2014.384","volume":"2","author":"XM Xu","year":"2014","unstructured":"Xu XM, Xie LC, Yuan LL, Hu XL, Jin JQ, Niu YM. Association of xeroderma pigmentosum complementation group G Asp1104His polymorphism with breast cancer risk: a cumulative meta-analysis. Mol Clin Oncol. 2014;2(6):1177\u201381.","journal-title":"Mol Clin Oncol"},{"issue":"11","key":"4815_CR19","first-page":"4174","volume":"7","author":"JF Luo","year":"2014","unstructured":"Luo JF, Yan RC, Zou L. XPG Asp1104His polymorphism and gastrointestinal cancers risk: a meta-analysis. Int J Clin Exp Med. 2014;7(11):4174\u201382. eCollection 2014.","journal-title":"Int J Clin Exp Med"},{"key":"4815_CR20","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1182\/blood-2004-06-2161","volume":"104","author":"JM Allan","year":"2004","unstructured":"Allan JM, Smith AG, Wheatley K, Hills RK, Travis LB, Hill DA, et al. Genetic variation in XPD predicts treatment outcome and risk of acute myeloid leukemia following chemotherapy. Blood. 2004;104:3872\u20137.","journal-title":"Blood"},{"issue":"1","key":"4815_CR21","first-page":"19","volume":"88","author":"I Moreno","year":"2003","unstructured":"Moreno I, Martin G, Bolufer P, Barrag\u00e1n E, Rueda E, Rom\u00e1n J, et al. Incidence and prognostic value of FLT3 internal tandem duplication and D835 mutations in acute myeloid leukemia. Haematologica. 2003;88(1):19\u201324.","journal-title":"Haematologica"},{"issue":"6","key":"4815_CR22","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.3109\/10428194.2012.736986","volume":"54","author":"JN Brewin","year":"2013","unstructured":"Brewin JN, Horne GA, Bisling KE, Stewart HJ, Chevassut TJ. Rapid detection of DNMT3A R882 codon mutations allows early identification of poor risk patients with acute myeloid leukemia. Leuk Lymphoma. 2013;54(6):1336\u20139. doi: 10.3109\/10428194.2012.736986 .","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"4815_CR23","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1007\/s11033-011-0998-5","volume":"39","author":"N Berhane","year":"2012","unstructured":"Berhane N, Sobti RC, Mahdi SA. DNA repair genes polymorphism (XPG and XRCC1) and association of prostate cancer in a north Indian population. Mol Biol Rep. 2012;39(3):2471\u20139.","journal-title":"Mol Biol Rep"},{"issue":"7","key":"4815_CR24","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/ajh.21726","volume":"85","author":"VM Guillem","year":"2010","unstructured":"Guillem VM, Cervantes F, Mart\u00ednez J, Alvarez-Larr\u00e1n A, Collado M, Cam\u00f3s M, et al. XPC genetic polymorphisms correlate with the response to imatinib treatment in patients with chronic phase chronic myeloid leukemia. Am J Hematol. 2010;85(7):482\u20136.","journal-title":"Am J Hematol"},{"issue":"1\u20132","key":"4815_CR25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.toxlet.2007.05.020","volume":"172","author":"J Topinka","year":"2007","unstructured":"Topinka J, Hertz-Picciotto I, Dostal M, Chvatalova I, Yap PS, Herr CE, et al. The DNA repair gene XPD\/ERCC2 polymorphisms Arg156Arg (exon 6) and Lys751Gln (exon 23) are closely associated. Toxicol Lett. 2007;172(1\u20132):85\u20139.","journal-title":"Toxicol Lett"},{"issue":"2","key":"4815_CR26","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.gene.2014.01.049","volume":"538","author":"D Liu","year":"2014","unstructured":"Liu D, Wu D, Li H, Dong M. The effect of XPD\/ERCC2 Lys751Gln polymorphism on acute leukemia risk: a systematic review and meta-analysis. Gene. 2014;538(2):209\u201316.","journal-title":"Gene"},{"key":"4815_CR27","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1158\/1055-9965.EPI-07-2507","volume":"17","author":"F Wang","year":"2008","unstructured":"Wang F, Chang D, Hu FL, Sui H, Han B, Li DD, et al. DNA repair gene XPD polymorphisms and cancer risk: a meta-analysis based on 56 case\u2013control studies. Cancer Epidemiol Biomarkers Prev. 2008;17:507\u201317.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"44","key":"4815_CR28","doi-asserted-by":"crossref","first-page":"8860","DOI":"10.5897\/AJB10.1839","volume":"10","author":"A \u00d6zcan","year":"2011","unstructured":"\u00d6zcan A, Pehlivan M, Tomatir AG, Karaca E, \u00d6zk\u0131nay C, \u00d6zdemir F, et al. Polymorphisms of the DNA repair gene XPD (751) and XRCC1 (399) correlates with risk of hematological malignancies in Turkish population. Afr J Biotechnol. 2011;10(44):8860\u201370.","journal-title":"Afr J Biotechnol"},{"issue":"1","key":"4815_CR29","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00438-014-0917-2","volume":"290","author":"Y Xu","year":"2015","unstructured":"Xu Y, Jiao G, Wei L, Wang N, Xue Y, Lan J, et al. Current evidences on the XPG Asp1104His polymorphism and melanoma susceptibility: a meta-analysis based on case\u2013control studies. Mol Genet Genomics. 2015;290(1):273\u20139.","journal-title":"Mol Genet Genomics"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-016-4815-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-016-4815-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-016-4815-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T19:06:01Z","timestamp":1567537561000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-016-4815-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,16]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["4815"],"URL":"https:\/\/doi.org\/10.1007\/s13277-016-4815-6","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,16]]}}}